Neisseria meningitidis

(redirected from Neisseria meningitis)

Neis·se·ri·a me·nin·gi·'ti·dis

a bacterial species found in the nasopharynx of humans but not in other animals; the causative agent of meningococcal meningitis and meningicoccemia; virulent organisms are strongly gram negative and occur singly or in pairs; in the latter case the cocci are elongated and are arranged with long axes parallel and facing sides kidney shaped; groups characterized by serologically specific capsular polysaccharides are designated by capital letters (the main serogroups being A, B, C, and D).

Neisseria meningitidis

Meningococcus Infectious disease A gram-positive coccus which is part of the normal nasopharyngeal flora; it is one of the most common causes of meningitis in the US

Neis·se·ri·a me·nin·gi·ti·dis

(nī-sēr'ē-ă men-in-jit'i-dis)
A species found in the nasopharynx; the causative agent of meningococcal meningitis. Virulent organisms are strongly gram-negative and occur singly or in pairs; in the latter case the cocci are elongated and are arranged with long axes parallel and facing sides kidney shaped. Groups characterized by serologically specific capsular polysaccharides are designated by capital letters (the main serogroups being A, B, C, and D).
Synonym(s): meningococcus.

Neisser,

Albert Ludwig S., German physician, 1855-1916.
Neisseria catarrhalis
Neisseria flavescens
Neisseria gonorrhoeae - a species that causes gonorrhea in humans. Synonym(s): Neisser coccus
Neisseria lactamica
Neisseria meningitidis
Neisseria sicca
Neisseria subflava
Neisseria - a genus of aerobic to facultatively anaerobic bacteria (family Neisseriaceae) that are parasites of animals.
Neisseria mucosa
Neisser coccus - Synonym(s): Neisseria gonorrhoeae
Neisser diplococcus
Neisser syringe - a urethral syringe used in treatment of gonococcal urethritis.
References in periodicals archive ?
'The introduction of 'Men A' vaccine into the EPI schedule will provide protection against Neisseria Meningitis Serotype A,' Shuaib said.
The signs of septic shock and the rapid deterioration of the patient "may lead us to consider the possibility of meningococcemia." Meningococcemia is caused by bacteria called Neisseria meningitis.
Hib immunization has eliminated almost all the cases of meningitis caused by Haemophilus influenza B whereas Streptococcus Pneumonia and Neisseria meningitis are common pathogens leading to meningitis.
In parts of sub-Sahara Africa with the highest HIV prevalence, cryptococcal meningitis is now the leading cause of community-acquired meningitis ahead of Streptococcus pneumoniae and Neisseria meningitis (3).
"The State Ministry of Health has so far collected 11 CSF [Cerebrospinal fluid] samples, these were tested and 8 of them tested positive for Neisseria Meningitis sero group A using latex agglutination testing (Pastorex rapid test)," partly reads the release, signed by Kariom Makur, the ministry's undersecretary.
"When you think about the bugs that we've been successful in developing vaccines to, they generally have a single main virulence factor that you can target: either a capsule, like Haemophilus influenzae, Streptococcus pneumoniae, or Neisseria meningitis, or a toxin, as in tetanus or diphtheria.
Neisseria meningitis is a gram-negative bacterium that occasionally causes invasive disease in humans, primarily meningitis or sepsis (1).
Menactra was first licensed in January 2005, and it is indicated for use in persons aged 11 to 55 years to prevent invasive meningococcal disease caused by several Neisseria meningitis serogroups including A, C, and Y.
Menactra was first licensed in January 2005, and it is indicated for use in persons aged 11-55 years to prevent invasive meningococcal disease caused by several Neisseria meningitis serogroups including A, C, and Y.
Menactra, which was first licensed in January 2005, is indicated for use in persons aged 11-55 years to prevent invasive meningococcal disease caused by several Neisseria meningitis serogroups including A, C, and Y.
Neisseria meningitis is one of the many bacteria that cause the disease.
The Group B version of the bacteria Neisseria meningitis claims about 150 lives a year.